Cargando…

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer

Purpose: Gastric cancer (GC), one of the world's top five most common cancers, is the third leading cause of cancer related death. It is urgent to identify non-invasive biomarkers for GC. The objective of our study was to find out non-invasive biomarkers for early detection and surveillance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Ruihuan, Zhao, Junjie, Qin, Wenjun, Zhang, Zejian, Zhao, Ran, Han, Jing, yang, Yupeng, Li, Lixiao, Wang, Xuefei, Ren, Shifang, Sun, Yihong, Gu, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556655/ https://www.ncbi.nlm.nih.gov/pubmed/28819389 http://dx.doi.org/10.7150/jca.17900

Ejemplares similares

A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

The Value of Serum Immunoglobulin G Glycome in the Preoperative Discrimination of Peritoneal Metastasis from Advanced Gastric Cancer
por: Qin, Ruihuan, et al.
Publicado: (2019)

Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling
por: Qin, Ruihuan, et al.
Publicado: (2020)

Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2018)

Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types
por: Ren, Shifang, et al.
Publicado: (2016)

Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics
por: Zhang, Xingwang, et al.
Publicado: (2014)

Relative Quantitation of Subclass-Specific Murine IgG Fc N-Glycoforms by Multiple Reaction Monitoring
por: Han, Jing, et al.
Publicado: (2020)

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
por: Zhong, Ailing, et al.
Publicado: (2019)

Generalized low levels of serum N‐glycans associate with better health status
por: Fan, Jiteng, et al.
Publicado: (2023)

Integrated glycomic analysis of ovarian cancer side population cells
por: Zhao, Ran, et al.
Publicado: (2016)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp
por: Zhao, Ran, et al.
Publicado: (2017)

Discovery of N-glycan Biomarkers for the Canine Osteoarthritis
por: Lee, Hyunjun, et al.
Publicado: (2020)

Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database
por: Wang, Xuefei, et al.
Publicado: (2019)

Tumor-Associated Glycans and Immune Surveillance
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2013)

The B-Cell-Specific Ablation of B4GALT1 Reduces Cancer Formation and Reverses the Changes in Serum IgG Glycans during the Induction of Mouse Hepatocellular Carcinoma
por: Sha, Jichen, et al.
Publicado: (2022)

The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer
por: Liu, Long, et al.
Publicado: (2013)

Glycan microarray: Toward drug discovery and development
por: Muthana, Saddam M.
Publicado: (2020)

Identification of metabolism-related genes for predicting peritoneal metastasis in patients with gastric cancer
por: Tian, Chenyu, et al.
Publicado: (2022)

Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy
por: Peng, Peike, et al.
Publicado: (2016)

Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
por: Liu, Hao, et al.
Publicado: (2016)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015)

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer
por: Sun, Jie, et al.
Publicado: (2021)

Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer
por: Peng, Peike, et al.
Publicado: (2016)

Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2019)

LC–MS Profiling of N-Glycans Derived from Human Serum Samples for Biomarker Discovery in Hepatocellular Carcinoma
por: Tsai, Tsung-Heng, et al.
Publicado: (2014)

Diagnostic Potential of Plasma IgG N-glycans in Discriminating Thyroid Cancer from Benign Thyroid Nodules and Healthy Controls
por: Zhang, Zejian, et al.
Publicado: (2021)

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients
por: LI, HE, et al.
Publicado: (2015)

High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy
por: Chen, Hao, et al.
Publicado: (2017)

Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer
por: He, Hongyong, et al.
Publicado: (2013)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
por: Shu, Ping, et al.
Publicado: (2017)

EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal
por: Li, Haojie, et al.
Publicado: (2022)

Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery
por: Trinh, Duong N., et al.
Publicado: (2022)

Dual Roles of Gastric Gland Mucin-specific O-glycans in Prevention of Gastric Cancer
por: Nakayama, Jun
Publicado: (2014)

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms
por: Zhang, Qi, et al.
Publicado: (2021)

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer
por: Wang, Hongshan, et al.
Publicado: (2016)

SCF(FBW7)-mediated degradation of Brg1 suppresses gastric cancer metastasis
por: Huang, Li-Yu, et al.
Publicado: (2018)

G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b41uk59mk3o6e4mg8d5jem1v4a